Strategies for Engineered Negligible Senescence (SENS) is a plan designed by Aubrey de Grey to develop technologies that will prevent and reverse the progress of biological aging. Central to the strategies of this plan is the view that aging is caused by the accumulation of molecular and cellular damage. The objective of SENS is to develop treatments that are periodically applied to remove such accumulated damage. The philosophy of SENS, as stated by its author, is that knowledge of aging mechanisms is not as important as it is to obtain results, i.e it does not matter why it works, provided it works.
The SENS targets and proposed solutions are:
| SENS target
| Solution
|
| Nuclear DNA mutations
| Whole-body Interdiction of Lengthening of Telomeres
|
| Mitochondrial DNA mutations
| Allotopic expression of mitochondrial genes
|
| Proliferation of unwanted cells
| Whole-body Interdiction of Lengthening of Telomeres
|
| Depletion of important cells
| Stem cell therapeutics
|
| Accumulation of intracellular waste
| Xenolysozymes
|
| Accumulation of extracellular waste
| Immune modulation, synthetic peptide aggregate breakers
|
| Accumulation of protein crosslinks
| Synthetic peptide crosslink disruptors
|
External link